Sutro Biopharma (STRO) Balance Sheet: Assets & Liabilities

Sutro Biopharma (STRO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Sutro Biopharma reported total assets of $173.83M and total liabilities of $306.28M. Shareholders' equity was negative at −$132.45M, meaning liabilities exceed assets. Total debt stood at $15.67M against $141.43M in cash and short-term investments, a net cash position of $125.75M.

Sutro Biopharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sutro Biopharma, Inc. (STRO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Mar 2019	Dec 2017
Current Assets
Cash and Cash Equivalents	58.13	190.30	69.27	47.25	30.41	206.15	4.96	125.30	22.02
Short-Term Investments	83.30	126.59	306.35	287.11	167.52	161.99	112.90	79.19	0.00
Cash & Short-Term Investments	141.43	316.90	375.62	334.36	197.94	368.14	117.86	204.49	22.02
Accounts Receivable	3.98	8.62	36.08	7.12	12.45	5.56	6.30	2.49	1.62
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.52	17.80	9.85	11.67	8.12	4.49	4.41	5.93	1.99
Total Current Assets	150.93	343.31	421.54	353.15	218.52	378.18	128.57	209.95	25.63
Non-Current Assets
Property, Plant & Equipment (Net)	21.55	35.87	44.76	51.06	51.59	12.94	9.63	10.93	14.00
Long-Term Investments	0.00	0.00	0.00	-32.02	68.78	0.00	15.62	0.02	0.22
Other Non-Current Assets	1.35	8.03	4.44	34.75	2.53	2.99	2.54	2.24	0.92
Total Non-Current Assets	22.90	43.90	49.19	53.79	122.89	15.93	27.80	13.19	15.14
Total Assets	173.83	387.21	470.74	406.94	341.41	394.11	156.37	223.14	40.77
Current Liabilities
Accounts Payable	7.57	10.48	9.44	4.80	6.01	5.54	5.58	3.06	2.90
Short-Term Debt	7.78	7.48	4.06	21.67	9.38	0.00	1.00	4.72	14.56
Current Portion of Long-Term Debt	-	-	4.06	12.50	9.38	-	-	-	-
Accrued Liabilities	49.22	27.22	19.41	27.91	19.82	8.82	-	-	-
Deferred Revenue	10.56	69.78	20.67	16.76	5.50	14.60	19.47	21.57	10.71
Other Current Liabilities	49.22	4.01	3.90	23.32	2.75	9.45	6.92	7.06	3.78
Total Current Liabilities	75.13	131.89	93.75	66.55	41.74	29.60	32.97	36.42	31.96
Non-Current Liabilities
Long-Term Debt	7.89	15.67	23.15	33.35	15.74	24.55	8.88	10.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Other Non-Current Liabilities	1.69	1.69	1.69	0.12	0.15	1.82	0.54	0.58	104.66
Total Non-Current Liabilities	231.15	210.71	227.34	123.35	47.11	32.47	25.61	55.18	117.81
Total Liabilities	306.28	342.61	321.09	189.90	88.84	62.06	58.58	91.60	149.77
Stockholders' Equity
Common Stock	0.01	0.01	0.06	0.06	0.05	0.05	0.02	0.02	0.00
Retained Earnings	-977.96	-786.87	-559.41	-452.62	-333.41	-227.87	-195.75	-150.33	-115.01
Accumulated Other Comprehensive Income	0.02	0.04	0.02	-0.62	-0.31	0.13	0.17	-0.05	-0.21
Additional Paid-in Capital	845.48	831.42	708.98	670.22	586.24	559.75	293.35	281.89	6.22
Shares Outstanding	8.58	8.25	6.10	5.75	4.63	-	-	-	-
Total Stockholders' Equity	-132.45	44.60	149.65	217.05	252.56	332.05	97.79	131.54	-109.00
Total Liabilities & Equity	173.83	387.21	470.74	406.94	341.41	394.11	156.37	223.14	40.77

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sutro Biopharma Balance Sheet

How much debt does Sutro Biopharma have?

Sutro Biopharma had total debt of $15.67M as of Dec 31, 2025, against $141.43M in cash and short-term investments. Total debt was $23.15M a year earlier.

What are Sutro Biopharma's total assets?

Sutro Biopharma reported total assets of $173.83M as of Dec 31, 2025, down 55.1% from $387.21M a year earlier. Total liabilities were $306.28M.

What is Sutro Biopharma's shareholders' equity?

Sutro Biopharma's shareholders' equity was negative at −$132.45M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition